Cell-cell fusion in sexually reproducing organisms is a mechanism to merge gamete genomes and, in multicellular organisms, it is a strategy to sculpt organs, such as muscle, bone, and placenta. Moreover, this mechanism has been implicated in pathological conditions, such as infection and cancer. Studies of genetic model organisms have uncovered a unifying principle: cell fusion is a genetically programmed process. This process can be divided in three stages: competence (cell induction and differentiation); commitment (cell determination, migration, and adhesion); and cell fusion (membrane merging and cytoplasmic mixing). Recent work has led to the discovery of fusogens, which are cell fusion proteins that are necessary and sufficient to fuse cell membranes. Two unrelated families of fusogens have been discovered, one in mouse placenta and one in Caenorhabditis elegans (syncytins and F proteins, respectively). Current research aims to identify new fusogens and determine the mechanisms by which they merge membranes.
Fusion proteins: the elusive key to cell-cell fusion
The emerging field of cell-cell fusion aims to understand where, when, how, and why two or more cells merge to develop into a new organism (sexual fusion) or to generate diverse giant multinucleate cells that sculpt distinct organs (nonsexual cell fusion). Fused cells can undergo dramatic changes in signaling and behavior and acquire new developmental fates. During fertilization, there is a barrier to further fusion events, whereas in somatic cellcell fusion, the fused cells are often competent and sometimes committed for new rounds of fusion, forming giant syncytia, as occurs in muscles and epithelia.
Genetic model organisms have been used to characterize the process of cell-cell fusion at different levels, often by studying fusion-defective phenotypes, unraveling different
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Glossary
Anchor cell fusion failure 1 (AFF-1): a protein essential for the fusion of the anchor cell with eight gonadal cells and additional epithelial and myoepithelial cell fusions in Caenorhabditis elegans. It was the second member of the F family of fusogens to be identified. CD9: integral membrane protein required for fertilization in mice and a member of the tetraspanin family. It is associated with integrins and other membrane proteins. Cytotrophoblast cells (CTBs): mononucleated progenitor cells of the placenta that can differentiate into extravillous trophoblast cells or fuse to form or increase the size of the multinucleated syncytiotrophoblast. Epithelial fusion failure 1 (EFF-1): an integral membrane protein essential and sufficient for epithelial and myoepithelial fusions in C. elegans. EFF-1 was the first F family fusogen to be discovered. Fusion competent myoblast (FCM): naive myoblasts capable of fusing to founder cells during Drosophila muscle formation. These cells account for the bulk of the myoblasts that form the muscles in Drosophila. Fusogen: a molecule (usually a protein) that fuses biological membranes. Founder cell (FC): muscle precursor or pioneer cells that establish a muscle prepattern in Drosophila. Generative cell specific 1 (GCS1): a membrane-associated factor critical to gamete fusion in various eukaryotes. Germ tube: polar-growing hypha emerging from a fungal spore. Hypha: thread-like multinucleated growth form of many fungi. IZUMO1: immunoglobulin superfamily type I transmembrane protein with one extracellular Ig-like domain. Spermatozoa from Izumo1-deficient mice fail to fuse with eggs. Parabiosis: the surgical or natural union of anatomical parts of two organisms. Podosome-like structures (PLS): structures containing an actin core with a surrounding ring of adhesive proteins that form a single domain 300-1500 nm between the FCM and FC/myotube that provides cytoplasmic continuity. Redundant: term used here in the context of yeast gamete fusion. A gene is redundant if additional loss of function of one or more genes in the same mating partner is needed to observe a phenotype. Syncytiotrophoblast (STB): multinucleated, terminally differentiated syncytium in the placenta formed by fusion of CTBs. Syncytin: the ENV protein of an endogenous retrovirus. Syncytium: multinucleated cell often resulting from cell fusion. Unilateral: term used here in the context of yeast gamete fusion. A gene is unilateral if loss of function in both mating partners is needed to observe a phenotype. The viral fusion machinery and syncytins are unilateral because the fusogen is only present in the virus or in one of the fusing cells. By contrast, EFF-1 and AFF-1 are required in both fusing cells; therefore, the fusion machinery is not unilateral but homotypic or bilateral. Vesicular stomatitis virus (VSV): an enveloped virus related to rabies used as a model system to study membrane fusion and intracellular traffic. stages of this process. Fusion competence is the first step of this process (Figure 1a) , allowing cells to overcome mechanisms that prevent fusion. The next step, commitment, requires cell-cell interactions, induction, and activation of the fusion machinery (Figure 1b) . Finally, cells are fused through the merging of the main barriers that define cells. The fusion of the plasma membranes and mixing of the cytoplasms constitute two unique steps in the pathway (Figure 1c) .
A major conceptual framework in the field is the existence of specific proteins on the surface of cells that are essential and sufficient to mediate merging of the cell membranes by taking part directly in cell-cell fusion. These cell fusion proteins (fusogens; see Glossary) have been the Holy Grail of the field for decades, but recently two independent and unrelated families of fusogens have been identified and characterized. The two families are required for fusion of epithelial cells. One family (the syncytins) contains diverse proteins that originated from endogenous retroviruses related to the HIV gp41 envelope glycoprotein and function during fusion of the placental trophoblasts that form the syncytial trophoblasts essential for mouse placentation. The second family (the F fusion proteins) is responsible for diverse and numerous cell fusions in the skin and digestive and reproductive organs of the nematode Caenorhabditis elegans.
The hunt is on now to identify the missing fusogens in other species. These may be members of the two known families of cell-cell fusogens, may be related to another family of viral membrane fusogens, or may be novel. Identifying these proteins may be complicated because, based on work on viral fusogens, it is the overall structure of these proteins rather than the primary sequence that is conserved [1] [2] [3] [4] [5] .
This review covers emerging genetic mechanisms and cell biological principles that control and mediate the process of sexual and somatic cell-cell fusion. Although there are several intriguing reports of cell-cell fusion involving stem cells, there is little information on the genetic basis of stem cell-cell fusion mechanisms. Therefore, we focus here on recent findings relating to sexual and somatic cell fusion in a variety of genetic systems, highlighting the distinct contributions of each model system to the field. We discuss examples of sexual nonself fusion in diverse genetic model organisms, followed by somatic self-fusion in fungi, flies, worms, mice, and humans. In particular, we focus on how hyphal cells fuse to form tubular networks in Neurospora, how myoblasts fuse to form multinuclear myofibers in diverse genetic model animals, how macrophages fuse to form osteoclasts and giant cells, how epithelia fuse to give rise to syncytiotrophoblasts in the placenta, and how one-third of all somatic cells fuse to form diverse organs in worms.
Sexual cell-cell fusion (gamete fusion) Despite the great diversity in size, shape, and behavior of gametes from different species, it still takes two to tango: sexual reproduction requires two gametes that fuse and merge their genomes. Here, we discuss recent advances in sexual cell fusion in some representative genetic model organisms, including mice, fungi, plants, protists, and worms.
Egg CD9 and sperm IZUMO1 are required for fertilization in mice In mice, only two key genes have been identified that are essential in sperm-egg fusion, izumo sperm-egg fusion 1 (Izumo1) in the spermatozoon and Cd9 in the oocyte. Loss of these factors leads to a sterile phenotype, but currently there is no demonstration that they act as fusogens. 
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Trends in Genetics July 2013, Vol. 29, No. 7 However, the fact that the requirement for these factors can be overcome by bypassing the fusion step via intracytoplasmic sperm injection suggest that they make specific contributions to egg-sperm fusion [6] [7] [8] [9] . IZUMO1, which was named after a Japanese marriage shrine, was initially identified by a sperm-egg fusioninhibiting monoclonal antibody. Mice deficient in Izumo1 produce spermatozoa that appear morphologically normal, bind and penetrate the zona pellucida surrounding the egg, but are not capable of fusing with eggs [9] . IZUMO1 is initially hidden in the acrosomal organelle under the plasma membrane. After exocytic fusion between the acrosome and the plasma membrane, it relocates to the surface of the sperm head, suggesting that redistribution of IZUMO1 is essential for fusion [9] .
CD9 (a tetraspanin) was shown to be required for fusion on the egg plasma membrane [6] [7] [8] . It was proposed that exosome-like CD9-containing vesicles are secreted from unfertilized eggs, thereby conferring fusion competence to the spermatozoon [10] . However, this experiment could not be reproduced in independent laboratories [11, 12] . In addition to the sterility phenotype, Cd9
À/À mice have altered length, thickness, and density of the microvilli of the eggs, suggesting that CD9 participates in microvilli formation and that microvilli are important for sperm-egg fusion [13] . There is no evidence indicating that IZUMO1 and CD9 directly interact during sperm-egg fusion. Even though IZUMO1 and CD9 are essential for sperm-egg fusion, it is still unclear how they participate in the process and if other proteins are also involved.
Fertilization in plants, protists, and invertebrates
Investigation of fertilization in other model organisms has uncovered a diverse set of genes required for this process. Recently, a male gamete-specific protein from lily pollen, Generative cell specific 1 (GCS1)/HAP2, was identified as a crucial factor in double fertilization in plants [14, 15] . Interestingly, GCS1/HAP2 orthologs have been found in various protists, including Chlamydomonas and Plasmodium, and in some cases, these orthologs have been shown to have a role in fertilization [14, 16, 17] . Despite this, GCS1/HAP2 and related proteins have not been reported to be sufficient for cell-cell fusion; thus, they are not considered fusogens.
Self-fertilizing C. elegans hermaphrodites generate equal numbers of sperm and oocytes ($300), all of which fuse as pairs. Similarly, high fusion efficiencies are found in sexual crosses where the number of gametes produced is higher ($1000). These and other characteristics make C. elegans a convenient genetic system to study sperm-egg fusion. Extensive genetic screens identified genes required for different stages of fertilization, but none have been shown to be sufficient to fuse gametes without the participation of other genes [18] .
Although there are essential genes for fertilization in some species, the sufficiency for cell membrane fusion has not been reported in heterologous cells. The fact that no genes have been found in plants, protists, or worms that are sufficient for fusion does not necessarily imply that no such genes exist in these groups. However, it is not expected that these fusogens will be conserved between worms and mice, based on the diverse fusogens that have been found (see below; [1] ).
Gamete fusion is regulated by PRM1 in yeast and filamentous fungi
In the Saccharomyces cerevisiae mating process, haploid cells differentiate into gametes, which fuse and form a diploid zygote (Figure 2a ). Pheromone-regulated multispanning membrane protein 1 (PRM1) was identified as a candidate protein involved in cell fusion through a combination of in silico analysis and functional characterization of mating-specific integral membrane proteins [19] . It is a tetra-spanning integral membrane protein that forms disulfide-linked homodimers and localizes at the cell fusion zone [20, 21] . prm1 mating pairs show three alternative phenotypes: (i) arrest with both plasma membranes apposed; (ii) successful fusion; or (iii) lysis [19, 22] . Lysis appears to be a byproduct of the fusogenic activity, suggesting that PRM1 has a regulatory role in this process. It has been hypothesized that, in its absence, a misregulated fusogen compromises membrane integrity, leading to lysis instead of fusion [22] [23] [24] . However, this model remains untested because there are no known fusogens in yeast. Several candidate fusogens have emerged from recent genetic screens, including genes involved in cell polarization or cell wall remodeling [25] [26] [27] [28] , but none appear to act as a bona fide fusogen. PRM1 has a conserved function in the filamentous fungus Neurospora crassa in both sexual fusion and vegetative cell merger (see below). Similar to yeast, approximately 50% of N. crassa prm1 fusion pairs arrest at the stage of plasma membrane merger [29] . It is currently unknown whether lysis occurs in N. crassa prm1 fusion events.
The lack of success in identifying fusogens suggests they are essential, redundant, bilateral (required in both fusing cells), or multigenic. Thus, biochemical or bioinformatics approaches may be more helpful in finding fusogens. Furthermore, future studies in a range of organisms should identify other fusion-related proteins involved in gamete fusion, and it will be interesting to determine whether there are common principles for gamete fusion, or whether this process varies among species. Sex determination evolves very rapidly, and it is possible that gamete fusion follows this trend.
Asexual cell-cell fusion (somatic cell fusion) Asexual fusion, which is usually homotypic, is important for vegetative growth in fungi and sculpting organs in multicellular animals. However, there are exceptions to these generalizations. During the asexual development of multicellular organisms, numerous somatic cells fuse to create and sculpt organs and build reticular networks in a process called 'self-fusion'.
The formation of tubular networks in N. crassa Neurospora crassa colonies comprise a syncytial network of highly polarized, growing, multinucleated hyphae. Its life cycle includes at least four different experimentally tractable cell fusion events, allowing comparison of specific molecular factors in these different processes. During colony initiation, germinating spores mutually attract, grow
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Trends in Genetics July 2013, Vol. 29, No. 7 towards each other, and fuse, forming a cellular network, which further develops into a mycelial colony. Genetic analysis identified numerous mutants affected in this asexual fusion. However, with the exception of Dprm-1, all mutants were defective in steps preceding the plasma membrane merger, such as competence, cell-cell signaling, or directed growth (Figure 1 ). Cell communication in germling fusion depends on components homologous to the highly conserved yeast pheromone response mitogenactivated protein (MAP) kinase (MAK) module [30, 31] , which adopt, however, unusual subcellular dynamics in N. crassa. While two fusion germlings grow towards each other, MAK-2 (homologous to Fus3p) oscillates from the cytoplasm to the plasma membrane in the region of the growing cell tip (Figure 2b ) [32] . This dynamic localization alternates with SOFT (SO), a cytoplasmic protein of unknown molecular function. The anti-phase oscillation of MAK-2 and SO indicates that tightly controlled and coordinated protein concentration and localization ensures fusion occurs when and where it should. The two cells that will fuse might alternate between signal sending and receiving in a type of cell-cell dialog [32] [33] [34] . Mathematical modeling indicated this would allow efficient fusion partner signaling by a single signal-receptor system while preventing self-excitation [34] . This example illustrates that sophisticated mechanisms have evolved to ensure that two fusion cells establish a stable and efficient interaction within a larger population of genetically and developmentally identical individuals.
Myoblast fusion: invasion by podosome-like structures During mammalian muscle development, thousands of myoblasts fuse to form the myofiber. Work in fly, zebrafish, and mouse has identified many genes required for myoblast fusion, which have been detailed in recent reviews [35] [36] [37] . One of the unifying features of these factors is their participation in Arp2/3-mediated actin polymerization [38] . In Drosophila, muscle fibers form via fusion between a founder cell (FC)/myotube and a fusion competent myoblast (FCM). The fusion interface between the FC/myotube and FCM is identified by an actin-rich structure [39] [40] [41] [42] (Figure 3 ). The distribution of actin at the fusion site is asymmetric: the FC/myotube builds a thin sheath of actin [43] , whereas the FCM provides a dense actin network termed the 'actin focus' (Figure 3a ) [43] [44] [45] . Consistent with cellular asymmetry of the fusion site, many actin regulatory genes, including WASp [40] [41] [42] 46, 47] , Verpolin/WIP/Solitary [41] [42] [43] , Blown Fuse [48] , and Mbc/Dock180 [44] , are necessary only in the FCM, whereas SCAR/WAVE [39, 43, 46, 47] is necessary in both fusion partners (Figure 3c ).
3D reconstruction indicates that the actin focus is lined with the FC-FCM immunoglobulin (Ig)-domaincontaining adhesive proteins [43, 45, 49] . Ultrastructural studies have further identified three to four protrusions from the FCM, which invade the apposing FC/myotube [43] . Based on their invasiveness, size, and actin core with a surrounding ring of adhesive proteins, these structures have been called 'podosome-like structures' (PLS) [43, 44, 49] . Similar structures have been identified in cancer cells (invadopodia), macrophages, osteoclasts, and tissue culture cells (podosomes), and they are associated with cell adhesion, migration, and invasion, as well as ECM protease secretion; all functions that could facilitate cell fusion [43, 45, 49] . Unlike the other invasive structures, PLS are unique in that they form a single domain of 300-1500 nm between the FCM and FC/myotube that is believed to participate in the generation of cytoplasmic continuity between fusing myoblasts [43, 50] . However, it is unclear how the initial fusion pores form and whether the PLS participates in pore formation and expansion. Although the existing invadopodia and/or podosome literature suggests new regulators of fusion [45, 51] , for example, ECM proteases and cortactin are hallmarks of these structures [51] , whether these function in myoblast fusion is unknown. Moreover, the links between actin, PLS, and membrane dynamics that lead to cytoplasmic continuity are still unclear.
Macrophage fusion: regenerative and pathologic Macrophage fusion, both homotypic (macrophage-macrophage) and heterotypic (macrophage-somatic), occurs in the dynamic process of tissue remodeling and/or regeneration and in pathogenic states. Continued investigation into aspects of macrophage fusion promises to shed light on the regenerative-pathogenic axis of this unique and important function.
Homotypic macrophage fusion: osteoclasts and multinucleated giant cells. Homotypic fusion of macrophages in mice (and humans) occurs in bone and tissues affected by chronic inflammation. In bone, multinucleated macrophages (osteoclasts) mediate bone resorption essential for skeletal stability. In other circumstances (generally called 'multinucleated giant cells'), the function of fused macrophages is unknown [52] .
Macrophage fusion can generate osteoclasts through cytokine induction with macrophage colony stimulating factor (M-CSF) and receptor activator of nuclear factor (NF)-kB ligand (RANKL) or giant cells through . Links between these pathways exist (e.g., Blow!Kette). Please refer to recent reviews for details on the genetic and physical interactions required for actin during myoblast fusion [35] [36] [37] .
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interleukin-4 (IL-4) and/or granulocyte macrophage colony stimulating factor (GM-CSF) [52] . Despite distinct pathways, the molecular machinery involved appears to be at least partially shared [52] . The function of the molecules upregulated during macrophage fusion supports the importance of proteolysis, cytoskeletal rearrangements, chemotaxis, migration, lipid recognition, and cell-cell attachment in the process [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] (Figure 4 ). Intriguingly, several molecules shown to be involved in macrophage fusion are also important in phagocytosis. Phagocytosis involves several membrane fusion events, and fusion may represent an alternative process to the engulfment of one macrophage by another. For IL-4-induced macrophage fusion, it was shown that all fusion partners must receive the IL-4 stimulus [63] , but that macrophages lacking selected molecules or expressing only part of the fusion machinery can still fuse with a fully fusion-competent macrophage [63, 64] . This shows that macrophage fusion between 'donor' and 'acceptor' macrophages is possible. As described below, a fusogenic 'donor' macrophage may even fuse with other cells, such as tumor cells. Based on current data from homotypic macrophage fusion events, we assume that these heterotypic fusion partners (e.g., cancer cells) display discrete molecular properties not found in other cells.
Heterotypic macrophage fusion in tumor pathogenesis
The concept that cell fusion plays a role in cancer pathogenesis spans a century, stemming from the observation of spontaneous cancer-somatic cell fusion in culture [65] . The combination of two genomes into a single cell presents an alluring basic mechanism for the gain of chromosomal instability, aberrant gene expression, and acquisition of novel cellular behaviors that can potentiate tumor aggressiveness and metastatic disease. However, there is little mechanistic evidence and even less physiologic validation in human tumors substantiating the hypothetical link between cancer and cell fusion.
Recently, in vivo demonstration of robust fusion between cancer cells and macrophages was reported in mouse models that used either bone marrow transplantation or parabiosis to facilitate introduction of marked bone marrow-derived cells into tumor-bearing mice [66, 67] . Although functional transfer of the macrophage cell behavior to the cancer cell remains to be demonstrated, transcriptome analysis of isolated cell fusion hybrids revealed retention of macrophage gene expression within the cell fusion hybrid cell [66] . This finding supports the possibility that macrophage fusion with cancer cells could provide a mechanistic link for the acquisition of metastatic properties encompassing those native to the macrophage (e.g., intravasation, extravasation, or tissue colonization).
The evidence for cancer-blood cell fusion in humans is weaker, although there are several case reports from gender mismatched bone marrow transplant patients who later went on to develop a solid tumor malignancy (e.g., [68] ). Furthermore, evidence of cancer cell fusion has been frequently documented in patients with multiple myeloma by tracking gene translocations [69] . However, clear demonstration of a physiologic and biologic impact of cancer cell fusion in human disease remains elusive.
Epithelia fusion in placenta
The placenta is a transitory organ that connects the fetus to the uterine wall, allowing nutrient uptake, waste elimination, and gas exchange to ensure embryonic development [70] . The syncytiotrophoblast (STB), formed by fused trophoblast cells, is a critical domain of the placenta required for nutrient exchange and secretion, among other functions [70, 71] . In humans, trophectoderm cells in contact with the 
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Myosin IIA Figure 4 . Macrophage fusion is a highly regulated, induced process. To fuse, macrophages acquire a fusion-competent phenotype through the integration of different signals: cytokines (e.g., RANKL + M-CSF or IL-4), cell-cell interaction (e.g., via TREM-2/DAP12 [53] ), and the respective intracellular signaling pathways (NF-kB, NFATc1, STAT6, syk [52, 54, 55] ). Genes essential for and upregulated during fusion include the chemokine CCL2, the putative multiple transmembrane receptors DC-STAMP and OC-STAMP, the cell adhesion molecule E-cadherin, and MMP9 [52, [55] [56] [57] . Cytoskeletal rearrangements required for fusion are mediated by RAC1 and DOCK180 [52] . Proteinases may influence fusion by cleavage, activation, and/or degradation of other proteins, such as CD44 or myosin IIA [58, 59] . By contrast, the matrix metalloproteinase MT1MMP seems to regulate RAC1 activity during fusion independently of proteolytic function [60] . Another crucial factor for macrophage fusion is the release of ATP via the P2X 7 receptor and recognition of adenosine by the receptor Adora1 [61, 62] . In addition, exposure of phosphatidylserine and lipid recognition by CD36, as well as surface receptors recognizing macrophage-expressed ligands, such as CD200 and SIRPa, have been shown to be involved [52] . Tetraspanins (CD9/CD81) act as molecular membrane organizers and appear to play an inhibitory role in macrophage fusion [52] . The mechanistic basis of the actual membrane fusion step has not been elucidated so far. Abbreviations: CCL-2, chemokine (C-C motif) ligand 2; DAP12, DNAX activation protein 12; DC/OC-STAMP, dendritic cell-specific transmembrane protein/ osteoclast stimulatory transmembrane protein; DOCK180, dedicator of cytokinesis 1; IL-4, interleukin 4; M-CSF, macrophage colony-stimulating factor; MMP9, matrix metalloproteinase 9; RAC1, Ras-related C3 botulinum toxin substrate 1; RANKL, receptor activator of nuclear factor (NF)-kB ligand; NFATc1, nuclear factor of activated T cell 1; STAT6, signal transducer and activator of transcription 6; syk, spleen tyrosine kinase; SIRPa, signal-regulatory protein alpha.
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embryoblast and the maternal endometrium generate the primary STB by intercellular fusion during peri-implantation. The secondary STB, which is formed 1-2 weeks after implantation and throughout pregnancy, is a single, multinucleated, and highly dynamic syncytium maintained by the continuous fusion of cytotrophoblast cells (CTBs) with the neighboring STB [70] (Figure 5a ). The murine STB resides in the placental labyrinth and is a two-layered structure (SynT-I and SynT-II, which never fuse) [72] ( Figure 5b ). Hormones, growth factors, cytokines, protein kinases, transcriptional factors, and membrane proteins regulate the complex anatomy and physiology of the placenta [70, 71] .
Endogenous retroviral syncytins are required and sufficient to fuse cells. One unique aspect of trophoblast syncytialization is the involvement of Syncytin1 and -2 endogenous retrovirus (ENV) genes of human ENVs [71] . Syncytin-1 appears to be predominantly expressed in the STB, whereas Syncytin-2 is only detected in the villous CTBs [70] (Figure 5a ). Both syncytins are sufficient to induce cell-cell fusion in different cell lines in a receptordependent manner, suggesting they are bona fide fusogens [70] . The disulfide bridge-forming CX 2 C and CX 7 C motifs of syncytins are essential for their fusogenic activities [73] .
Syncytin-A and Syncytin-B are murine ENV genes homologous to the primate Syncytin genes, and they localize to SynT-I and SynT-II, respectively [74] (Figure 5b ). Deletion of either Syncytin gene leads to impaired formation of the corresponding STB layer [75, 76] , suggesting distinct yet essential roles during trophoblast fusion for these syncytins. Syncytin-related genes have also been identified in Leporidae and Canidae [77, 78] . Because none of these Syncytins are orthologous [78] , it has been suggested that they were captured by their hosts independently between 12 million and 85 million years ago and account for the different structures of placentas among different species [78] . However, it is still not clear why some mammals utilize fusogens of viral origin to execute the fusion process in the placenta; in addition, although syncytin genes are described as placenta-specific genes, the fusogenic activity of human Syncytin-1 has also been implicated in the fusion events of nontrophoblast cells, including cancer cells [79] and osteoclasts [80] .
The observation that the STB is not completely absent in Syncytin-knockout mice [75] suggests the existence of yet unknown fusogens. The mechanism of trophoblast fusion supports the working hypothesis that viral-like fusogens will also merge myoblasts, macrophages, and gametes, but this has not yet been shown.
Programmed cell fusion is essential to sculpt organs in C. elegans Over 300 somatic cells (out of $1000) fuse to form syncytial muscles in the pharynx and epithelia in the skin, vulva, hymen, uterus, pharynx, excretory system, and glands in C. elegans [81] [82] [83] . Genetic screens have identified two genes, eff-1 and aff-1, that fuse and sculpt cells in C. elegans [1, [81] [82] [83] . Whereas fusion failure results in deformities, ectopic migration of unfused epithelial cells, behavioral defects, and low fertility, abnormal expression of EFF-1 or AFF-1 causes excess cell fusion and embryonic lethality [81] [82] [83] .
EFF-1 and AFF-1 proteins are essential and sufficient to fuse cells. eff-1 is required for the initiation and expansion of fusion pores [81, 82, 84, 85] . EFF-1 and AFF-1 are type I membrane glycoproteins that belong to a family of homotypic cell-cell fusogens (F family) essential for somatic cell fusion. F proteins can fuse heterologous insect and mammalian cells via a hemifusion intermediate [83, 86, 87] . Moreover, enveloped viruses with F proteins substituted for their native fusogens are capable of infecting mammalian cells, which provides further evidence that they are bona fide fusogens ( Figure 6 ) [87] .
F proteins execute self-and autofusion of cells in development. F proteins also mediate autofusion, whereby specific cellular domains of pharyngeal muscles, epithelial excretory duct cell, glia, and neurons fuse with themselves in C. elegans [88] [89] [90] [91] [92] [93] . For example, both pm8 and vpi1 autofuse to become two mononucleated donut-shaped cells [89] . Autofusion may have been undetected in other biological systems such as in phagocytosis, immunity, generation of small capillaries, and neurons. The difficulty of identifying an autofusion event is that the outcome of autofusion is the formation of a cell with a different shape. However, because of the almost invariant cellular development of C. elegans, several autofusion events were characterized, although this was possible only after mutants that specifically failed to fuse were identified. In other genetic systems, it will be necessary to first find the unidentified fusogens and then discover an intermediate that would reveal that the cell fused to itself to generate a new shape.
Diverse signaling pathways, transcription factors, and vacuolar ATPase control the activities of eff-1 and aff-1 [83, [94] [95] [96] [97] [98] [99] [100] . For example, Notch signaling simultaneously induces AFF-1 and represses EFF-1 expression in pm8 muscle cells [89] . Thus, precise spatial and temporal regulation of F activity is essential to determine and maintain a stereotypic pattern of cell-cell and autofusions.
Although somatic fusogens have been characterized, the germ cell fusogens are as yet unknown (see sexual fusions above). F proteins have been identified in 47 species, comprising mostly nematodes, but also ctenophores, arthropods, one chordate, and one protist. These fusion proteins are believed to evolve rapidly and the conservation is probably structural [87] . To identify structurally related F proteins acting in sexual and asexual reproduction, muscle development, bone development, placenta formation, immunity, stem cell, and cancer cell fusion, it will be necessary to identify the precise structural and functional signatures essential for cell fusion.
Concluding remarks
Different genetic model systems have recently contributed a distinct mechanistic understanding of the process of cell fusion. Although no universal mechanism may exist, the field is actively searching for unified concepts and unidentified fusogens. At the same time, we are exploring the specific roles of the actin cytoskeleton in myoblast fusion, cytokine induction of macrophage fusion, the links between fusion and lysis in yeast, reciprocal, alternating signaling in Neurospora, the connections between cancer and cell fusion, the specific functions of different syncytins in the generation of diverse placental giant multinucleated cells, 
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Trends in Genetics July 2013, Vol. 29, No. 7 and the biophysical mechanisms of F protein-mediated cell-cell fusion. Thus, cell fusion mechanistic research is still an embryonic field in an exciting stage of development.
Three structural classes of authentic fusogenic membrane glycoproteins have been discovered in enveloped viruses, and recent research has uncovered two unrelated families of cellular fusogens, suggesting that dedicated fusogens specific for each cell fusion process are waiting to be discovered and characterized. Some researchers in the field believe that 'spontaneous cell fusion' occurs in biology in the absence of fusogens or dedicated machinery. However, the F family of fusogens in nematodes and other species and the endogenous retroviral family of mammalian syncytins in the placenta demonstrate that overcoming the barriers that prevent spontaneous cell-cell fusion in nature requires a dedicated machinery of fusion proteins. Thus, it is expected that genuine fusogens will be found in all organisms. We strongly believe that a combination of genetic, biochemical, and biophysical approaches will eventually identify and characterize these elusive proteins required for fertilization and organ formation.
